Cargando…
Medication Discrepancies in Community Pharmacies in Switzerland: Identification, Classification, and Their Potential Clinical and Economic Impact
Background: Transitions of care are high-risk situations for the manifestation of medication discrepancies and, therefore, present threats for potential patient harm. Medication discrepancies can occur at any transition within the healthcare system. Methods: Fifth-year pharmacy students assessed a b...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151719/ https://www.ncbi.nlm.nih.gov/pubmed/32182863 http://dx.doi.org/10.3390/pharmacy8010036 |
_version_ | 1783521314627125248 |
---|---|
author | Imfeld-Isenegger, Tamara L Pham, Melanie Bich Tram Stämpfli, Dominik Albert, Valerie Almanasreh, Enas Moles, Rebekah Chen, Timothy F Hersberger, Kurt E |
author_facet | Imfeld-Isenegger, Tamara L Pham, Melanie Bich Tram Stämpfli, Dominik Albert, Valerie Almanasreh, Enas Moles, Rebekah Chen, Timothy F Hersberger, Kurt E |
author_sort | Imfeld-Isenegger, Tamara L |
collection | PubMed |
description | Background: Transitions of care are high-risk situations for the manifestation of medication discrepancies and, therefore, present threats for potential patient harm. Medication discrepancies can occur at any transition within the healthcare system. Methods: Fifth-year pharmacy students assessed a best possible medication list (BPML) during a medication review (based on medication history and patient interview) in community pharmacies. They documented all discrepancies between the BPML and the latest medication prescription. Discrepancies were classified using the medication discrepancy taxonomy (MedTax) classification system and were assessed for their potential clinical and economic impact. Results: Overall, 116 patients with a mean age and medication prescription of 74 (± 10.3) years and 10.2 (± 4.2), respectively, were analyzed. Of the 317 discrepancies identified, the most frequent type was related to strength and/or frequency and/or number of units of dosage form and/or the total daily dose. Although, the majority of discrepancies were rated as inconsequential (55.2%) on health conditions, the remainder posed a potential moderate (43.2%) or severe impact (1.6%). In 49.5% of the discrepancies, the current patients’ medication cost less than the prescribed. Conclusion: Community pharmacies are at a favorable place to identify discrepancies and to counsel patients. To improve patient care, they should systematically perform medication reconciliation whenever prescriptions are renewed or added. |
format | Online Article Text |
id | pubmed-7151719 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71517192020-04-20 Medication Discrepancies in Community Pharmacies in Switzerland: Identification, Classification, and Their Potential Clinical and Economic Impact Imfeld-Isenegger, Tamara L Pham, Melanie Bich Tram Stämpfli, Dominik Albert, Valerie Almanasreh, Enas Moles, Rebekah Chen, Timothy F Hersberger, Kurt E Pharmacy (Basel) Article Background: Transitions of care are high-risk situations for the manifestation of medication discrepancies and, therefore, present threats for potential patient harm. Medication discrepancies can occur at any transition within the healthcare system. Methods: Fifth-year pharmacy students assessed a best possible medication list (BPML) during a medication review (based on medication history and patient interview) in community pharmacies. They documented all discrepancies between the BPML and the latest medication prescription. Discrepancies were classified using the medication discrepancy taxonomy (MedTax) classification system and were assessed for their potential clinical and economic impact. Results: Overall, 116 patients with a mean age and medication prescription of 74 (± 10.3) years and 10.2 (± 4.2), respectively, were analyzed. Of the 317 discrepancies identified, the most frequent type was related to strength and/or frequency and/or number of units of dosage form and/or the total daily dose. Although, the majority of discrepancies were rated as inconsequential (55.2%) on health conditions, the remainder posed a potential moderate (43.2%) or severe impact (1.6%). In 49.5% of the discrepancies, the current patients’ medication cost less than the prescribed. Conclusion: Community pharmacies are at a favorable place to identify discrepancies and to counsel patients. To improve patient care, they should systematically perform medication reconciliation whenever prescriptions are renewed or added. MDPI 2020-03-09 /pmc/articles/PMC7151719/ /pubmed/32182863 http://dx.doi.org/10.3390/pharmacy8010036 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Imfeld-Isenegger, Tamara L Pham, Melanie Bich Tram Stämpfli, Dominik Albert, Valerie Almanasreh, Enas Moles, Rebekah Chen, Timothy F Hersberger, Kurt E Medication Discrepancies in Community Pharmacies in Switzerland: Identification, Classification, and Their Potential Clinical and Economic Impact |
title | Medication Discrepancies in Community Pharmacies in Switzerland: Identification, Classification, and Their Potential Clinical and Economic Impact |
title_full | Medication Discrepancies in Community Pharmacies in Switzerland: Identification, Classification, and Their Potential Clinical and Economic Impact |
title_fullStr | Medication Discrepancies in Community Pharmacies in Switzerland: Identification, Classification, and Their Potential Clinical and Economic Impact |
title_full_unstemmed | Medication Discrepancies in Community Pharmacies in Switzerland: Identification, Classification, and Their Potential Clinical and Economic Impact |
title_short | Medication Discrepancies in Community Pharmacies in Switzerland: Identification, Classification, and Their Potential Clinical and Economic Impact |
title_sort | medication discrepancies in community pharmacies in switzerland: identification, classification, and their potential clinical and economic impact |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151719/ https://www.ncbi.nlm.nih.gov/pubmed/32182863 http://dx.doi.org/10.3390/pharmacy8010036 |
work_keys_str_mv | AT imfeldiseneggertamaral medicationdiscrepanciesincommunitypharmaciesinswitzerlandidentificationclassificationandtheirpotentialclinicalandeconomicimpact AT phammelaniebichtram medicationdiscrepanciesincommunitypharmaciesinswitzerlandidentificationclassificationandtheirpotentialclinicalandeconomicimpact AT stampflidominik medicationdiscrepanciesincommunitypharmaciesinswitzerlandidentificationclassificationandtheirpotentialclinicalandeconomicimpact AT albertvalerie medicationdiscrepanciesincommunitypharmaciesinswitzerlandidentificationclassificationandtheirpotentialclinicalandeconomicimpact AT almanasrehenas medicationdiscrepanciesincommunitypharmaciesinswitzerlandidentificationclassificationandtheirpotentialclinicalandeconomicimpact AT molesrebekah medicationdiscrepanciesincommunitypharmaciesinswitzerlandidentificationclassificationandtheirpotentialclinicalandeconomicimpact AT chentimothyf medicationdiscrepanciesincommunitypharmaciesinswitzerlandidentificationclassificationandtheirpotentialclinicalandeconomicimpact AT hersbergerkurte medicationdiscrepanciesincommunitypharmaciesinswitzerlandidentificationclassificationandtheirpotentialclinicalandeconomicimpact |